Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLRS
2751
Kalaris Therapeutics
KLRS
$96.8M
| $518K | ﹤0.01% |
33,129
+18,619
| +128% | +$734K |
|
|
TVRD
2752
Tvardi Therapeutics
TVRD
$23.4M
| $518K | ﹤0.01% |
19,362
+10,698
| +123% | +$443K |
|
2753
Ohio Valley Banc Corp
OVBC
$205M
| $517K | ﹤0.01% |
22,475
-100
| -0.4% | -$2.37K |
|
2754
Lesaka Technologies
LSAK
$420M
| $516K | ﹤0.01% |
159,276
+11,876
| +8% | +$46.3K |
|
2755
Mid Penn Bancorp
MPB
$952M
| $516K | ﹤0.01% |
+21,269
| New | +$453K |
|
2756
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$364M
| $516K | ﹤0.01% |
6,100
-7,000
| -53% | -$607K |
|
2757
SCYNEXIS
SCYX
$52M
| $515K | ﹤0.01% |
28,868
+22,088
| +326% | +$324K |
|
2758
Simulations Plus
SLP
$371M
| $515K | ﹤0.01% |
+11,500
| New | +$456K |
|
2759
Santander
BSBR
$43.5B
| $514K | ﹤0.01% |
78,500
+68,000
| +648% | +$401K |
|
2760
Dianthus Therapeutics
DNTH
$6.09B
| $513K | ﹤0.01% |
49,306
+14,090
| +40% | +$156K |
|
|
PARAA
2761
DELISTED
Paramount Global Class A
PARAA
| $513K | ﹤0.01% |
26,103
+2,100
| +9% | +$35.9K |
|
2762
Applied Optoelectronics
AAOI
$11.5B
| $510K | ﹤0.01% |
26,400
-841,179
| -97% | -$11M |
|
|
DNMR
2763
DELISTED
Danimer Scientific, Inc.
DNMR
| $509K | ﹤0.01% |
+12,468
| New | +$678K |
|
2764
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
| $508K | ﹤0.01% |
+20,500
| New | +$493K |
|
|
HYPD
2765
Hyperion DeFi Inc
HYPD
$40.9M
| $507K | ﹤0.01% |
3,048
-2,329
| -43% | -$275K |
|
2766
iShares US Infrastructure ETF
IFRA
$4.57B
| $507K | ﹤0.01% |
12,600
-3,700
| -23% | -$138K |
|
2767
Value Line
VALU
$361M
| $507K | ﹤0.01% |
10,400
+100
| +1% | +$4.26K |
|
|
OPOF
2768
DELISTED
Old Point Financial
OPOF
| $506K | ﹤0.01% |
28,235
+1,600
| +6% | +$27K |
|
2769
Appian
APPN
$2.48B
| $505K | ﹤0.01% |
+13,400
| New | +$524K |
|
2770
Asure Software
ASUR
$250M
| $505K | ﹤0.01% |
53,000
-15,600
| -23% | -$130K |
|
2771
Fidelity D&D Bancorp
FDBC
$317M
| $505K | ﹤0.01% |
8,700
| – | – |
|
2772
Avita Medical
RCEL
$240M
| $505K | ﹤0.01% |
36,800
-34,400
| -48% | -$394K |
|
2773
Telesat
TSAT
$897M
| $503K | ﹤0.01% |
48,182
+24,282
| +102% | +$272K |
|
|
TE
2774
T1 Energy
TE
$1.63B
| $503K | ﹤0.01% |
+269,200
| New | +$726K |
|
|
SLAI
2775
DELISTED
SOLAI Ltd ADS
SLAI
| $502K | ﹤0.01% |
+14,226
| New | +$350K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.